| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.08 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |